High sucrose diets promote intestinal epithelial cell proliferation and tumorigenesis in APCMin Mice by Increasing Insulin and IGF-I Levels

Nutrition and Cancer

Volumn 61, Issue 1, 2009, Pages 81-93

  Wang, Bing ^a   Bobe, Gerd ^a   LaPres, John J ^b   Bourquin, Leslie D ^a  

^a Michigan State University   (United States)

^b Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN; KI 67 ANTIGEN; MESSENGER RNA; SOMATOMEDIN C; STARCH; SUCROSE; SULINDAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APC MIN MOUSE; ARTICLE; BODY WEIGHT; CARCINOGENESIS; CELL PROLIFERATION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; FEEDING; FEMALE; GLUCOSE BLOOD LEVEL; INCIDENCE; INSULIN BLOOD LEVEL; INTESTINE EPITHELIUM CELL; LABELING INDEX; LIVER; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PAPILLOMA; SMALL INTESTINE; SUGAR INTAKE; WILD TYPE;

ANIMALS; CARCINOGENS; CELL DIVISION; COLONIC NEOPLASMS; DIETARY SUCROSE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FEMALE; GENES, APC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION;

MUS;

EID: 58149144411     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802372609     Document Type: Article

References (56)

1. American Cancer Society: Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society, 2007.
2. Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA, et al.: Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5, 38-52, 1994.
3. De Stefani E, Mendilaharsu M, and Deneo-Pellegrini H: Sucrose as a risk factor for cancer of the colon and rectum: a case-control study in Uruguay. Int J Cancer 75, 40-44, 1998.
4. Kristiansen E and Thorup IM: Influence of different diets on development of DMH-induced aberrant crypt foci and colon tumor incidence in Wistar rats. Nutr Cancer 23, 151-159, 1995.
5. Caderni G, Dolara P, Spagnesi T, Lucerni C, Bianchini F, et al.: Rats fed high starch diets have lower colonic proliferation and faecal bile acids than high sucrose-fed controls. J Nutr 123, 704-712, 1993.
6. Caderni G, Luceri C, Spagnesi MT, Giannini A, Biggeri A, et al.: Dietary carbohydrates modify azoxymethane-induced intestinal carcinogenesis in rats. J Nutr 124, 517-523, 1994.
7. Poulsen M, Molck AM, Thorup I, Breinholt V, and Meyer O: The influence of simple sugars and starch given during pre- or post-initiation on aberrant crypt foci in rat colon. Cancer Lett 167, 135-143, 2001.
8. Caderni G, Luceri C, Spagnesi MT, Giannini A, Biggeri A, et al.: Dietary carbohydrates modify azoxymethane-induced intestinal carcinogenesis in rats. J Nutr 124, 517-523, 1994.
9. McKeown-Eyssen GE: Epidemiology of colorectal cancer revisited: are serum triglyceride and/or plasma glucose associated with risk? Cancer Epidemiol Biomark Prev 3, 687-695, 1994.
10. Giovannucci E: Insulin and colon cancer. Cancer Causes Control 6, 164-179, 1995.
11. Giovannucci E: Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131, 3109S-3120S, 2001.
12. Storlien LH, Kraegen EW, Jenkins AB, and Chisholm D: Effects of sucrose vs starch diets on in vivo insulin action, thermogenesis, obesity in rats. Am J Clin Nutr 47, 420-427, 1988.
13. Pagliassotti MJ and Prach PA: Quantity of sucrose alters the tissue pattern and time course of insulin resistance in young rats. Am J Physiol 269, R641-R646, 1995.
14. Thresher JS, Podolin DA, Wei Y, Mazzeo RS, and Pagliassotti MJ: Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance. Am J Physiol 279, R1334-R1340, 2000.
15. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, et al.: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91, 620-625, 1999.
16. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, et al.: A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9, 345-349, 2000.
17. Wu Y, Yakar S, Zhao L, Hennighausen L, and LeRoith D: Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62, 1030-1035, 2002.
18. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87, 159-170, 1996.
19. Chiu CH, McEntee MF, and Whelan J: Sulindac causes rapid regression of preexisting tumors in Min mice independent of prostaglandin biosynthesis. Cancer Res 57, 4267-4273, 1997.
20. Sørensen IK, Kristiansen E, Mortensen AJ, Nicolaisen GM, Wijnands IAH, et al.: The effect of soy isoflavones on the development of intestinal neoplasia in Apc Min mouse. Cancer Lett 130, 217-225, 1998.
21. Min mice fed suboptimal levels of sulindac. J Agric Food Chem 54, 9322-9328, 2006.
22. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, et al.: Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670, 1992.
23. Reeves PG, Nielsen FH, and Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institution of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951, 1993.
24. Corpet DE and Pierre F: Point: from animal models to prevention of colon cancer: systematic review of chemoprevention in Min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 12, 391-400, 2003.
25. Corpet DE and Pierre F: How good are rodent models of carcinogenesis in predicting efficacy in humans?: a systematic review and meta-analysis of colon chemoprevention in rats, mice andmen. Eur J Cancer 41, 1911-1922, 2005.
26. Busserolles J, Rock E, Gueux E, Mazur A, Grolier P, et al.: Short-term consumption of a high-sucrose diet has a pro-oxidant effect in rats. Br J Nutr 87, 337-342, 2002.
27. Dragsted LO, Daneshvar B, Vogel U, Autrup HN, Wallin H, et al.: A sucrose-rich diet induces mutations in the rat colon. Cancer Res 62, 4339-4345, 2002.
28. Mahmoud NN, Boolbol SK, Dannenberg AJ, Mestre JR, Bilinski RT, et al.: The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis 19, 87-91, 1998.
29. McEntee MF, Chiu CH, and Whelan J: Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice. Carcinogenesis 20, 635-640, 1999.
30. Yang K, Fan K, Kurihara N, Shinozaki H, Rigas B, et al.: Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations. Carcinogenesis 24, 605-611, 2003.
31. Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen AJ, et al.: Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 346, 1054-1059, 2002.
32. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, et al.: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis with sulindac. N Engl J Med 328, 1313-1316, 1993.
33. Meyskens FL, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, et al.: Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res 1, 9-11, 2008.
34. Caderni G, Luceri C, Lancioni L, and Dolara P: Dietary sucrose, glucose, fructose, and starches affect colonic functions in rats. Nutr Cancer 25, 179-186, 1996.
35. Bromley M, Rew D, Becciolini A, Balzi M, Chadwick C, et al.: A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa. Eur J Histochem 40, 89-100, 1996.
36. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, et al.: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138, 867-873, 1991.
37. Holt PR, Moss SF, Kapetanakis AM, Petrotos A, and Wang S: Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen? Cancer Epidemiol Biomarkers Prev 6, 131-135, 1997.
38. Muskhelishvili L, Latendresse JR, Kodell RL, and Henderson EB: Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hydridization for histone mRNA. J Histochem Cytochem 51, 1681-1688, 2003.
39. Lipkin M: Phase I and phase II proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer. Cancer 34, 878-888, 1974.
40. Lipkin M, Blattner WA, Gardner EJ, Burt RW, Lynch H, et al.: Classification and risk assessment of individuals with familial polyposis, Gardner's syndrome, and familial non-polyposis colon cancer from [3H]thymidine labeling patterns in colonic epithelial cells. Cancer Res 44, 4201-4207, 1984.
41. Bleiberg H, Buyse M, and Galand P: Cell kinetic indicators of premalignant stages of colorectal cancer. Cancer 56, 124-129, 1985.
42. Terpstra OT, van Blankenstein M, Dees J, and Eilers GA: Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 92, 704-708, 1987.
43. Daly M: Sugars, insulin sensitivity, and the postprandial state. Am J Clin Nutr 78(Suppl), 865S-872S, 2003.
44. Niho N, Takahasi M, Kitamura T, Shoji Y, Itoh M, et al.: Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res 63, 6090-6095, 2003.
45. Mutoh M, Niho N, and Wakabayashi K: Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity. Biol Chem 387, 381-385, 2006.
46. Niho N, Mutoh M, Komiya, Ohta T, Sugimura T, et al.: Improvement of hyperlipidemia by indomethacin in Minmice. Int J Cancer 121, 1665-1669, 2007.
47. Wang B, Bobe G, LaPres JJ, and Bourquin LD: Dietary carbohydrate source alters gene expression profile of intestinal epithelium in mice. Nutr Cancer 61, 146-155, 2009.
48. Kondo H, Minegishi Y, Komine Y, Mori T, Matsumoto I, et al.: Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice. Am J Physiol Endocrinol Metab 291, E1092-E1099, 2006.
49. Ntambi JM, Miyazaki M, and Dobrzyn A: Regulation of stearoyl-CoA desaturase expression. Lipids 39, 1061-1065, 2004.
50. Wiedmer T, Zhao J, Li L, Zhou Q, Hevener A, et al.: Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). Proc Natl Acad Sci USA 101, 13296-13301, 2005.
51. Elliott SS, Keim NL, Stern JS, Teff K, and Havel PJ: Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76, 911-922, 2002.
52. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, and Kraegen EW: Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 49, 1155-1163, 1989.
53. Stewart CE and Rotwein P: Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76, 1005-1026, 1996.
54. Rajaram S, Baylink DJ, and Mohan S: Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18, 801-831, 1997.
55. Jones J and Clemmons D: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16, 3-34, 1995.
56. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, and Clemmons DR: Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 42, 145-151, 1994.